Author/Authors :
Farhadieh، R. D. نويسنده , , Ross D and Smee، نويسنده , , Robert and Ow، نويسنده , , Kim and Yang، نويسنده , , Jia Lin and Russell، نويسنده , , Pamela J and Crouch، نويسنده , , Roger and Jackson، نويسنده , , Paul T. Jacobson، نويسنده , , Ian V، نويسنده ,
Abstract :
Oral Squamous Cell Carcinoma (OSCC) is a common malignancy. Treatment failure is mainly due to loco-regional disease recurrence. KAI1 is a newly discovered metastasis suppressor gene.
seven patients with primary OSCC underwent surgery alone or surgery and adjuvant radiotherapy. Immunohistochemical evaluation of KAI1/CD82 and p53 proteins was carried out on specimen obtained at surgery.
neoplastic fields, KAI1/CD82 expression was downregulated and negative in 42/57 (73.7%) cases. p53 expression was positive in 26/57 (45.6%) cases. No correlation was noted between KAI1/CD82 and p53 expression or clinicopathological parameters. Univariate and multivariate Cox proportional hazard models showed a correlation between KAI1/CD82 expression with disease free survival (P=0.01, P=0.009) and overall survival (P=0.04, P=0.053) respectively.